- Home
- CPT vs SMMT Comparison
CPT vs SMMT Comparison
Compare CPT & SMMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPT
- SMMT
- Stock Information
- Founded
- CPT 1993
- SMMT 2003
- Country
- CPT United States
- SMMT United States
- Employees
- CPT N/A
- SMMT N/A
- Industry
- CPT Real Estate Investment Trusts
- SMMT Biotechnology: Pharmaceutical Preparations
- Sector
- CPT Real Estate
- SMMT Health Care
- Exchange
- CPT Nasdaq
- SMMT Nasdaq
- Market Cap
- CPT 12.6B
- SMMT 14.5B
- IPO Year
- CPT 1993
- SMMT N/A
- Fundamental
- Price
- CPT $121.65
- SMMT $18.15
- Analyst Decision
- CPT Buy
- SMMT Strong Buy
- Analyst Count
- CPT 21
- SMMT 4
- Target Price
- CPT $119.83
- SMMT $34.75
- AVG Volume (30 Days)
- CPT 929.4K
- SMMT 2.0M
- Earning Date
- CPT 10-31-2024
- SMMT 10-30-2024
- Dividend Yield
- CPT 3.42%
- SMMT N/A
- EPS Growth
- CPT 52.45
- SMMT N/A
- EPS
- CPT 3.17
- SMMT N/A
- Revenue
- CPT $1,556,549,000.00
- SMMT N/A
- Revenue This Year
- CPT N/A
- SMMT N/A
- Revenue Next Year
- CPT $2.69
- SMMT N/A
- P/E Ratio
- CPT $38.23
- SMMT N/A
- Revenue Growth
- CPT 1.45
- SMMT N/A
- 52 Week Low
- CPT $87.61
- SMMT $1.89
- 52 Week High
- CPT $127.69
- SMMT $33.89
- Technical
- Relative Strength Index (RSI)
- CPT 51.98
- SMMT 44.54
- Support Level
- CPT $118.70
- SMMT $18.31
- Resistance Level
- CPT $121.62
- SMMT $20.14
- Average True Range (ATR)
- CPT 2.36
- SMMT 1.35
- MACD
- CPT 0.27
- SMMT -0.20
- Stochastic Oscillator
- CPT 67.32
- SMMT 14.71
About CPT Camden Property Trust
Camden Property Trust is a real estate investment trust primarily engaged in the acquisition, management, and development of multifamily apartment communities across the United States. The company's real estate portfolio consists primarily of apartment properties throughout the Sun Belt. Houston, Dallas, Las Vegas, and Atlanta represent some of Camden's largest housing markets in terms of apartment units. The firm derives nearly all of its revenue from the leasing of properties to tenants through short-term agreements. Camden Property derives the majority of its revenue from the Washington D.C., Los Angeles, Houston, Atlanta, and southeastern Florida areas.
About SMMT Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.